This module has two key segments. In the morning, two topics will be discussed that have broad implications in the design and analysis of clinical trials: the role of biomarkers as replacement (i.e., surrogate) endpoints, and the interpretability of confirmatory vs. exploratory analyses; in the afternoon, attention will be given to a topic having broad implications in the conduct of clinical trials: the role of Data Monitoring Committees and current challenges in their implementation.